Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-02-04

Clinical Trial Update: Levulan PDT Versus Vehicle for Extremity Actinic Keratoses (AK) [Phase 2]

View source ↗

Summary

Phase 2 trial comparing Levulan photodynamic therapy to vehicle for actinic keratoses of the extremities; results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levulan PDT (5-aminolevulinic acid (5-ALA) photodynamic therapy)

Snippet

Sponsor: DUSA Pharmaceuticals, Inc. | Conditions: Keratosis, Actinic | Phase 2 | Status: COMPLETED | Results posted: 2013-02-04